Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Ingelsson

Showing results (41-50 of 217) with videos related to

Pageof 22
Sort By:
Circulation. Genomic and Precision Medicine|February 26, 2021
Life-Time Covariation of Major Cardiovascular Diseases: A 40-Year Longitudinal Study and Genetic StudiesLars Lind, Johan Sundström, Johan Ärnlöv, et al.
Lakartidningen|July 10, 2009
[Rare mutations aim toward future treatment]Martin Ingelsson, Hans Basun, Frida Ekholm Pettersson, et al.
Cellular and Molecular Neurobiology|December 29, 2016
Mapping of Surface-Exposed Epitopes of In Vitro and In Vivo Aggregated Species of Alpha-SynucleinLeire Almandoz-Gil, Veronica Lindström, Jessica Sigvardson, et al.
Chemistryopen|November 7, 2024
Distinct Chemical Determinants are Essential for Achieving Ligands for Superior Optical Detection of Specific Amyloid-β Deposits in Alzheimer's DiseaseXiongyu Wu, Hamid Shirani, Ruben Vidal, et al.
Neuroimage|June 26, 2021
In vivo imaging of synaptic density with [<sup>11</sup>C]UCB-J PET in two mouse models of neurodegenerative diseaseMengfei Xiong, Sahar Roshanbin, Johanna Rokka, et al.
Current Protocols in Human Genetics|April 23, 2008
Genotyping of apolipoprotein E: comparative evaluation of different protocolsMartin Ingelsson, Youngah Shin, Michael C Irizarry, et al.
Journal of Neuroinflammation|December 13, 2017
Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytesGabriel Gustafsson, Veronica Lindström, Jinar Rostami, et al.
Immunotherapy|February 5, 2014
Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disordersVeronica Lindström, Elisabet Ihse, Therese Fagerqvist, et al.
Journal of Proteome Research|March 11, 2014
Quantification of the brain proteome in Alzheimer's disease using multiplexed mass spectrometrySravani Musunuri, Magnus Wetterhall, Martin Ingelsson, et al.
Journal of Neurochemistry|May 6, 2019
Antibodies against alpha-synuclein: tools and therapiesNishant N Vaikath, Issam Hmila, Vijay Gupta, et al.
Pageof 22

Showing results (41-50 of 217) with videos related to

Sort By:
Pageof 22
Circulation. Genomic and Precision Medicine|February 26, 2021
Life-Time Covariation of Major Cardiovascular Diseases: A 40-Year Longitudinal Study and Genetic StudiesLars Lind, Johan Sundström, Johan Ärnlöv, et al.
Lakartidningen|July 10, 2009
[Rare mutations aim toward future treatment]Martin Ingelsson, Hans Basun, Frida Ekholm Pettersson, et al.
Cellular and Molecular Neurobiology|December 29, 2016
Mapping of Surface-Exposed Epitopes of In Vitro and In Vivo Aggregated Species of Alpha-SynucleinLeire Almandoz-Gil, Veronica Lindström, Jessica Sigvardson, et al.
Chemistryopen|November 7, 2024
Distinct Chemical Determinants are Essential for Achieving Ligands for Superior Optical Detection of Specific Amyloid-β Deposits in Alzheimer's DiseaseXiongyu Wu, Hamid Shirani, Ruben Vidal, et al.
Neuroimage|June 26, 2021
In vivo imaging of synaptic density with [<sup>11</sup>C]UCB-J PET in two mouse models of neurodegenerative diseaseMengfei Xiong, Sahar Roshanbin, Johanna Rokka, et al.
Current Protocols in Human Genetics|April 23, 2008
Genotyping of apolipoprotein E: comparative evaluation of different protocolsMartin Ingelsson, Youngah Shin, Michael C Irizarry, et al.
Journal of Neuroinflammation|December 13, 2017
Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytesGabriel Gustafsson, Veronica Lindström, Jinar Rostami, et al.
Immunotherapy|February 5, 2014
Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disordersVeronica Lindström, Elisabet Ihse, Therese Fagerqvist, et al.
Journal of Proteome Research|March 11, 2014
Quantification of the brain proteome in Alzheimer's disease using multiplexed mass spectrometrySravani Musunuri, Magnus Wetterhall, Martin Ingelsson, et al.
Journal of Neurochemistry|May 6, 2019
Antibodies against alpha-synuclein: tools and therapiesNishant N Vaikath, Issam Hmila, Vijay Gupta, et al.
Pageof 22